Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-133-9 | CAS number: 78-69-3
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Valid experimental data were available to assess the genetic toxicity of tetrahydrolinalool in-vitro.
Gene mutation in bacteria
In the key study according to OECD TG 471 and GLP, tetrahydrolinalool was evaluated for mutagenic activity in the Ames test (DSM B-167764) using the Salmonella typhimurium strains TA1535, TA97, TA98, TA100, and TA102 in the presence and absence of an exogenous metabolic activation system (rat liver S9). No significant increase in the number of revertant colonies was apparent in all five test strains after treatment with tetrahydrolinalool up to cytotoxic concentrations.It is therefore concluded, that neither tetrahydrolinalool nor respective metabolites are mutagenic in the Ames test under the described experimental conditions.
Further data, available in a summary publication, confirm that tetrahydrolinalool was not mutagenic in an Ames test with and without metabolic activation and tested up to 3600 μg/plate in Salmonella typhimurium TA1535, TA 1537, TA 98, TA 100 and TA 1538; metabolic activation consisted of liver S-9 mix from Aroclor-induced male rats (Wild 1983).
Gene mutation in mammalian cells
In the chosen key study, tetrahydrolinalool did no induce gene mutations in a HPRT assay using V79 cells (according to OECD TG 476 and GLP) up to cytotoxic concentrations with and without metabolic activation (BASFAG 50M0021/989002).
Cytogenicity in mammalian cells
In the chosen key study, i.e. a chromosomal abberation assay according to OECD TG 473 and GLP using V79 Chinese hamster fibroblasts, tetrahydrolinalool was found to be negative for causing chromosomal abberations up to cytotoxic concentrations with and without metabolic activation (BASFAG 32M0021/989001).
The test substance tetrahydrolinalool was found to be not mutagenic and not clastogenic in in-vitro experiments using rodent and bacterial cells.
Short description of key information:
Gene mutation in bacteria: S. typhimurium TA 1535, TA 97, TA 98, TA100 and TA 102, with and without metabolic activation (Ames test, OECD 471, GLP): negative (DSM B-167764)
Gene mutation in mammalian cells: V79 (HPRT test; OECD 476, GLP), with and without metabolic activation: negative (BASFAG 50M0021/989002)
Cytogenicity in mammalian cells: V79 (in vitro chromosomal abberation test; OECD 473, GLP), with and without metabolic activation: negative (BASFAG 32M0021/989001)
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
The present data on genetic toxicity do not fulfill the criteria laid down in regulation (EC) 1272/2008 and therefore, a non-classification is warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
